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Tuberculosis is the leading cause of infectious disease in Nepal. An estimated 60% of the
adult population aged between 15-45 years is infected with tuberculosis, and 45% of the total
population is infected. Ten percent of people infected with TB progress to active disease. To
combat tuberculosis, Directly Observed Therapy (DOT) was adopted in Nepal in 1996. DOT
was administered at four national demonstration sites in 1996 and expanded over time so that
56% of the population to date have been covered by DOT. This study aimed to evaluate DOT in
pulmonary TB patients in Nepal in terms of patient outcome and compliance. DOT was
compared against a conventional treatment program or self-administered therapy (SAT), which
served as the control group. The project was a retrospective nonconcurrant cohort study.
Patients were sputum positive pulmonary TB patients aged over 15 years from Bhaktapur district
in Nepal, who had undergone DOT or SAT between 1996 and 1998. Medical records of all the
patients were sent to the National TB Center in Thimi, Nepal. A total of 261 patients (DOT, 161
patients and SAT, 100 patients) were included in the study. The two groups were similar in
terms of age, ethnicity, and religion status. The cure rate was 86.3% for DOT, which was
significantly higher than the 75.0% for the SAT group (p<0.05). The compliance rate was also
higher for DOT at 90.2% versus 81.8% for the SAT group (p<0.05). The mean treatment length
was 6.8 months for the SAT group and 7.4 months for the DOT group (p<0.05).
Higher rates of treatment compliance and cure rate were achieved in the DOT group versus the

SAT group. Thus, DOT is advocated as a means of ensuring greater TB program success.
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CHAPTER 1
Introduction
Tuberculosis (TB) is a major infectious disease infecting over one third of the world's
population. The World Health Organization (WHO) estimates that 8 million of these infected
individuals develop active TB and two million die each year. WHO declared TB a global
emergency in April 1993. The reasons for this resurgence include the emergence of ADDS,
homelessness, an increase in multi-drug resistant cases, and the failure of many national TB
control programs (World Health Organization [WHO], 2000).
TB is now the leading cause of infectious disease in Nepal. An estimated 60% of the adult
population aged between 15-45 years are infected with tuberculosis, and 45% of the total
population are infected. Ten percent of people infected progress to active disease (World
Health Organization / His Majesty's Government of Nepal [WHO/HMG] Review, 1994).
This review found a case detection rate of 30% and a cure rate of only 40%. The review
team recommended that His Maj esty' s Government (HMG) of Nepal change the National TB
Control Program (NTP) strategy to achieve better results. As a result, the Directly Observed
Therapy (DOT) strategy was adopted in Nepal with the approval of a 5-year development
plan in 1995. Four national demonstration and training districts for DOT were established in
1996. On the basis of encouraging results of these districts, DOT is being expanded over time
to cover the entire population by the year 2003. To date, 52 out of 75 districts with 56% of
the population have been covered by DOT in Nepal (Bam, 2000). It remains to be seen
whether

DOT

in Nepal,

implemented

1

since

1996,

will

be

able to

achieve
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the WHO goals of an 85% cure rate in new sputum positive cases and a 70% case detection
rate among existing TB cases (WHO, 2000).
Purpose of the study
The purpose of this study was to evaluate Directly Observed Therapy in pulmonary TB
cases in Nepal. The researcher attempted to answer the following questions. What is the rate
of patients on DOT who complete the therapy as compared to TB patients getting selfadministered therapy (SAT)? What is the cure rate for patients with TB who receive DOT as
compared to TB patients getting self-administered therapy? The effectiveness of DOT was
compared against a conventional treatment program (self-administered therapy), which served
as the comparison group. The study also aimed to examine the attitude of providers towards
the effectiveness and administration of DOT.
Need for the study
With the high prevalence and incidence of cases, Nepal desperately needs an effective TB
intervention program. Directly Observed Therapy has proven to be an effective solution in
other parts of the world. But for any intervention to be successful there has to be local
evaluations and constant feedback to the program. Thus, the needs for this study are as
follows: (1) comparing the effectiveness of DOT with a conventional treatment program, (2)
measuring the attitudes of the providers towards the programs' effectiveness and
implementation, and (3) understanding the causes behind success or failure of the program.
The study results will be useful to the health policy planners, donor agencies, and health
care providers in Nepal. If the study determines that DOT has made a significant impact in
increasing patient compliance, that finding will have a positive effect on all concerned with TB
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prevention in Nepal.

Hypotheses
The following hypotheses were tested:
1) There will be no difference in patient compliance between patients receiving DOT versus
those receiving self-administered therapy;
2) There will be no difference in treatment success rates between patients receiving DOT
versus those receiving self-administered therapy.
Delimitations
This study was delimited to active TB cases attending TB clinics in the district of
Bhaktapur, Nepal. One group of patients received DOT and the second group received
conventional treatment. In the DOT group, all the patients had undergone treatment between
1997-1998. In the SAT group, patients had undergone treatment between 1996 and 1999.
Limitations
1) Since the study was retrospective and depended upon clinic records, attrition and accuracy
of reporting may have been a significant problem.
2) The study group and the comparison group may not be equivalent due to self-selection into
treatment centers.
3) Generalizability of the results was limited as the study only focused on TB patients in one
district.
Assumptions
1) The providers were honest in answering the questionnaire.
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2) The information provided in the medical records was accurate.
Definitions
Tuberculosis- A chronic, infectious disease caused by bacteria Mycobacterium Tuberculosis
that affects primarily the lung but can involve any organ of the body. The Acid Fast Bacilli
(AFB) test is an inexpensive and effective test to determine the presence of the bacteria in the
sputum. This study included only patients with pulmonary tuberculosis who were sputum
positive or active cases.
Patient outcome was divided into the following categories:
Transfer out- referred to formal referral, following diagnosis, of patients living in neighboring
districts to their own districtas health center for continuation of treatment.
Death- fatality while patient compliant with treatment.
Treatment discontinued- referred to patient initiated discontinuation of treatment, and a
patient was so classified if 4 weeks of treatment was missed.
Treatment completion- documented proof of taking every dose of a full six month treatment
under direct supervision.
Cured- Documented proof of treatment completion as well as sputum conversion from
positive to negative.
Treatmentfailure- In spite of treatment for 5 months, patient still producing positive sputum
and failure to record clinical improvement.
The following registration categories were used:
New - If the treatment received before was none or less than 4 weeks.
Relapse - Previously treated tuberculosis cases were classified as relapse if they become
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sputum positive after being treated successfully.
Return after defaulting - Interrupted treatment for more than two months and presented again
with positive sputum smear.

CHAPTER 2
Review of Literature
Nepal - An overview
Nepal is a land-locked country bordering China on the North and India on its three other
sides. It is a small kingdom about 500 miles long and 110 miles wide. Nepal has a total area
covering 56,827 square miles. Though small, it is a country of physical contrasts. The
lowlands in the south called Terai are only 200 Feet above sea level and the most fertile part
of the country. The remaining two-thirds of the country is covered by hills and mountains.
The north zone includes the Himalayas, with Mount Everest which is 29,028 Feet above the
sea level, lies on Nepal's border with Tibet.
The total population of Nepal is 22 million (1999). Hinduism is the predominant religion.
Ninety percent of the population is Hindus, 5% are Buddhists, and about 3% are Muslims.
Some 58 languages are in use, thus pointing out the ethnic diversity of the country although
Nepali is the mother tongue. The population structure is typical of a less developed nation,
with 40% of population below 15 years of age (median age, 19.9 years).
Administratively, Nepal is divided into 5 developmental regions, 14 zones, 75 districts,
3,913 village development committees, and 58 municipalities which include 1 metropolitan
and 4 sub-metropolitan cities. District populations range from 5,000 in the mountains
(Manang) to 676,000 in the terai (Morang). Nepal is one of the least developed countries of
the world, with a per capita income of $224 (1995/1996) and 60% of the population
estimated to be living below the poverty level. More than 90% of the population depend on
agriculture for their livelihood.

6

7
Major problems faced by Nepal include overpopulation and a lack of economic
opportunities and infrastructure. Due to the mountainous terrain most of the country is still
inaccessible by road. As a result of the practice of logging trees for firewood, which is the
major source of fuel energy, deforestation has wreaked havoc in terms of soil erosion and the
loss of fertile topsoil, thus giving rise to decreased agricultural productivity.
The Ministry of Health (MOH), a public agency, is the largest single health care provider
in Nepal. Established in 1950, the MOH has undergone restructuring from vertical projects
for the control of malaria, tuberculosis, leprosy, immunization, etc, to an integrated public
health system with emphasis on preventive care (Sigdel, 1998). Each district has a 25-bed
hospital responsible for health services to the local populace, as well as technical support to
health posts and primary care centers.

Each health post is run by a Health Assistant

(paramedic) serving a population of 10,000-50,000. Health posts provide limited curative
services, immunization, malaria and tuberculosis treatment, family planning activities, etc.
Apart from Health Assistants (HA), health posts are served by Auxiliary Nurse Midwives
(ANM) and Auxiliary Health Workers (AHW).

Health posts run outreach clinics for

immunization conducted by Village Health Workers (VHW). Kathmandu, the capital, has
most of the tertiary and university hospitals. The distribution of health services and health
manpower are unequal, with a greater concentration in the capital and many districts lacking
even a single doctor. The private sector consists of private, nonprofit providers such as the
Red Cross, United Mission to Nepal, etc. There are also many private for-profit hospitals,
and their numbers are increasing. Traditional healers called Dhamis and Jhakris are an integral
part of healing, especially in rural and remote villages. Appendix A contains an organizational
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chart of the Ministry of Health.
The health status of the Nepalese people is one of the worst in the world. The average life
expectancy is 57.3 years (Central Bureau of Statistics [CBS], 1999). The Maternal Mortality
Rate (MMR), 150 per 100,000 (CBS, 1999), helps account for this average. Another poor
indicator of the population's health status is the Infant Mortality Rate, which is 75 per 1000
live births (CBS, 1999). Infectious diseases such as diarrhea and lower respiratory infections
including pneumonia are the major killers among infants and children. Pregnant women often
receive no prenatal care, and deliveries in most cases are not assisted by trained health
workers. The end result is one of the highest MMRs in the world. The high rate of poverty
and illiteracy, lack of awareness, and inaccessibility to health care are the major reasons for
the poor health status. Table 1 contains the most recent and accurate health and demographic
indicators for Nepal.
Tuberculosis
Tuberculosis is an infectious airborne disease caused by the bacilli Mycobacterium
Tuberculosis. It is spread by air droplets when a patient with sputum positive TB coughs,
sneezes, spits or laughs releasing infected droplets, which can be inhaled by a susceptible
person. Tuberculosis primarily causes disease in the lung but can involve any organ. In the
immunosuppressed, TB bacilli can disseminate from the lungs to infect the brain, bones,
kidney and other vital organs.
Tuberculosis is a major infectious disease infecting more than one third of the world's
population. It is estimated that between 2000 and 2020, nearly one billion people will be
newly infected, 200 million will get sick, and 3 5 million will die from TB if control is not
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further strengthened (WHO, 2000). It has been 50 years since the first anti-tuberculosis drug

Table 1
Health Indicators of Nepal

Indicators

Nepal

Life expectancy

57.3 years
Male-57.1yrs, Female-57.6yrs (1999)

Crude Birth Rate

35.4 per 1000 population (1997-98)

Crude Death Rate

11.5 per 1000 population (1997-98)

Growth Rate

2.08 % (1996)

Population doubling time in years

32(1998)

Infant Mortality Rate

75 per 1000 live births (1999)

Under 5 Mortality Rate

104 per 1000 live births (1999)

Maternal Mortality Rate

150 per 100,000 live births (1999)

Literacy Rate

52.6% (1996)

Male Literacy Rate

67.9% (1996)

Female Literacy Rate

37.8 % (1996)

Population / Physician Ratio

16,830

Population / Nurse Ratio

4,680

Source: Central Bureau of Statistics: Statistical Year book of Nepal, 1999
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was discovered. Effective treatments capable of curing all patients in 6-8 months have been
available for the last 25 years. Despite these medications, there is growing morbidity and
mortality at the end of the twentieth century and the beginning of the twenty-first century.
Factors contributing to the rise of TB worldwide are (1) HIV, (2) poorly managed TB control
programs, and (3) migration (WHO, 2000).
Tuberculosis is the leading cause of infectious disease in Nepal, where an estimated 60%
of the adult population aged between 15-45 years are infected; 45% of the total population
are infected and 10% of these progress to active disease. The case detection ratio in Nepal
for TB is 50%. The patient compliance among the diagnosed cases registered for treatment is
40% (WHO/HMG Review, 1994). Thus, half the undiagnosed and untreated cases contribute
significantly to the spread of TB.

Among diagnosed cases an estimated 60% are

noncompliant, thus bringing about the emergence of multi-drug resistant strains of the
bacteria and further compounding the problem. It also is no surprise that TB is once again
increasing stigmatization among people with it, owing to the increase in drug resistant cases.
The reasons for increased TB prevalence in Nepal can be attributed to poverty, lack of
awareness, ineffective national TB control programs, a low case detection rate, noncompliance with treatment, and increasing drug-resistant cases. TB patients comprise a
significant percentage on any hospital's outpatient or inpatient population.

In an

epidemiological study of TB in a Mission hospital in Palpa district, TB ranked fourth as the
cause for admission. Pulmonary TB was the most common type and an important cause of
TB mortality. In the TB clinic of the hospital, 10-12 new cases were diagnosed everyday.
The authors also identified major problems such as drug supplies at health posts not being
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timely refurbished, a significant rate of defaulters, a low BCG vaccine coverage rate of 67%,
poor active case finding, and the inability to trace defaulters (Bhattacharya, Bhattarai, Malla,
Pandit, and Rajouria, 1994). A summary of the epidemiology of TB in Nepal is presented in
Table 2.
The following outline is a history of tuberculosis control activities in Nepal (Bam & Smith,
1996).
1) The pre-chemotherapy era: 1934-1950. TB sanitariums were built. These sanitariums
were situated in high altitudes as fresh air was thought to be a significantly helpful positive.
2) The standard chemotherapy era: 1951-1989.
3) The Tuberculosis Control Project was established in 1965. The main aim of this project
was to provide BCG vaccination. In the same year, 18-24 months of standard chemotherapy
with isoniazid and thiacetazone supplemented by 3 months of streptomycin injection was
introduced. The treatment length was later modified to a 12-month regimen.
4) The short course chemotherapy era: 1986-1995.

The discovery of Rifampicin and

Pyrazinamide revolutionized TB treatment. It became possible to complete treatment in 6-8
months.
5) The Directly Observed Therapy or DOT era from 1996 to the present.
In April 1996, four national demonstration and training centers for directly observed
therapy were started in the Bhaktapur, Kailali, Nawalparasi, and Parsa districts. Cure rates in
the first cohort of patients registered in these centers were 87% (Bam, 2000). In 1998, 37
demonstration sites were established with DOT covering 17% of the population. Presently
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Epidemiology of Tuberculosis in Nepal

Latent Infection: 60% of population aged 15-49
45% of the total population infected
10% of those infected develop TB
Incidence: 237/100,000 population (45% smear positive)
44,000 new cases arise annually (50% detected)
20,000 infectious or sputum positive cases every year
75% of cases are in young adults (15-44 years)
Low treatment completion rate (40% of those detected)
8000-11,000 people die of TB annually
15%) of new cases are in urban areas where 10% of the population lives

Source: His Majesty=s Government and World Health Organization Review, 1994.
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there are 131 treatment centers, covering over 56% of the population in 52 districts (Bam,
2000). These centers are either health posts or primary care centers under the Ministry of
Health. TB therapy is given under the supervision of Health Assistants and Auxiliary Health
Workers. The goal is to gradually expand the implementation of DOT to all 75 districts by
2003.
Directly Observed Therapy
Directly Observed Therapy has been hailed as the public health breakthrough of the decade
for TB control by the WHO. For the first time since the discovery of anti-tuberculosis drugs
in 1944 there is hope of reversing the global spread of tuberculosis. The concept of DOT
originated from studies done in India (Madras) and Hong Kong as early as 1950 (Bayer,
Wilkinson, 1995). However, it was not until the 1990s that supervised therapy became
widely used, due in part to concerns about cost and the infringement on people's liberties.
DOT is also a labor-intensive program. But DOT also appears to be the best way of ensuring
compliance. Prior to DOT, pill counting, urine testing and making unannounced home visits
were the only ways of trying to ensure compliance. In United States, the Advisory Council
for the Elimination of Tuberculosis (ACET) has recommended that DOT be used in all
locations that do not achieve a 90% treatment completion rate. This policy was enacted in
1993 (Advisory Council for the Elimination of Tuberculosis [ACET], 1993).
The WHO recommended DOT strategy combines five elements:(l) political commitment,
(2) case detection through sputum smear microscopy, (3) standardized short course treatment
for at least six to eight months, with direct observation of treatment for at least the initial two
months, (4) regular, uninterrupted supply of anti-TB drugs, and (5) standardized recording
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and reporting system (WHO, 2000). Once infectious cases have been detected using a
microscope, health and community workers observe patients swallowing the correct dosage
of anti-TB medicines. The DOT providers can be health personnel or trained peoplefromthe
community. No hospitalization is normally required and treatment can be delivered directly to
the patients in their community enabling them to continue working and remain with their
families. DOT may require patients to present themselves to the health care facility at the
required days, but DOT is also conducted in patients' homes. Anti-TB medication is given
intermittently or daily for 6-8 months. DOT produces cure rates of up to 95% even in the
poorest countries as seen in Peru where widespread use of DOT for more than five years has
led to the successful treatment of 91% of cases (WHO, 2000). With TB affecting a third of
the worlds' population, TB control by using DOT is one of the most important cost-effective
strategies in public health today. A six-month supply of drugs for DOT costs $11(US) per
patient in some parts of the world. The World Bank has ranked the DOT strategy as one of
the most cost-effective health interventions (WHO, 2000).
Related studies on Directly Observed Therapy
Many studies have been done in developed and less developed countries to evaluate the
effectiveness of DOT. The first study was in 1958 in Madras, India by Fox (Bayer &
Wilkinson, 1995). Fox observed that despite patients coming from a poverty stricken
community in a city with poor public transport (e.g., walking up to 5 miles to reach the clinic)
it was still possible to get patients to come six days a week for streptomycin injection and a
supervised oral dose of pyrazinamide. Thus, Fox concluded that ALong term daily supervised
administration can be organized under special circumstances, even in developing countries
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(Fox, 1962)."
In a study done by Chaulk, Moore-Rice, and Rizzo (1995) an evaluation of community
based directly observed therapy for TB control was done. The Baltimore City Health
Department (BCHD) in 1981 implemented a community outreach strategy where DOT was
provided at either a patient's home, workplace, school, drug treatment facility, city jail or
nursing home. The study, which was an 11-year retrospective descriptive study, compared
TB case rates, sputum conversion rates (SCR), rates of therapy completion and confounding
factors such as AIDS, immigration, unemployment and poverty.

DOT in Baltimore,

Maryland, was compared with five major US cities in 1981 where TB incidence was high but
where DOT was not used. Since 1981 when DOT was implemented, Baltimore, experienced
the greatest decline in TB incidence among the cities compared. The rate in Baltimore
declined from 35.6 cases per 100,000 population in 1981 to 17.2 cases per 100,000 in 1992.
The city ranked sixth in 1981 and 28th in 1992 in the incidence of TB cases. The average TB
incidence actually rose 2.1% in the five non- DOT comparison cities during the same period.
Baltimore's DOT managed cases had the highest annual SCRs at 3 months (mean equaled
90.7%) and the highest completion rates for standard anti-TB therapy (90.1%) when
compared to the five other cities. Thus, community based DOT facilitated higher treatment
completion rates and higher bacteriological evidence of cures.
In a study done by El-Sadr, Medard, and Barthaud (1996) in Harlem Hospital, New York,
DOT was found to result in a high treatment completion and visit adherence rate. Harlem had
one of the highest TB rates in the US (221 cases per 100,000 persons as compared to 10.5
nationwide) and a treatment completion rate of only 11%. DOT was started from 1993 and

the program used a family model approach whereby patients were made to feel that they
belonged to one big family with activities such as trips, birthday celebrations and various
incentives such as certificates, clothing, meal coupons, refreshments, etc. Out of 145 TB
cases enrolled, 95 continued with DOT. Injection drug use was reported by 46.2% of cases,
crack cocaine use by 16.5% and 57.9% were HIV infected. Still, there was a visit adherence
rate of 91% (the proportion of scheduled visits successfully completed within 24 hours). The
mean sputum culture conversion took about 11 weeks. The family model approach of DOT,
and the various incentives and enablers, could have contributed to the success of treating this
hard to reach population. Also crucial to the success was the enthusiasm and concern of the
staff, many of whom were themselves TB survivors.
A study was done by Norval, San, Bakhim, Rith, Ahn, and Blanc (1998) in Cambodia to
evaluate DOT. Cambodia has a severe TB problem with a new TB case notification rate of
150 per 100,000 population and a TB control program established in the early 1980s
achieving cure rates of only 40-50%. DOT was implemented in 1994 with funds from 13
sources.

The DOT strategy was initially introduced in 120 TB units in general public

hospitals. Two and half years after the start, DOT was implemented in 85% of all public
hospitals. In 1996 the case detection rate had reached 127 per 100,000 population for smear
positive TB and 149 per 100,000 for all TB. Ninety percent of all TB patients receivedDOT.
From January 1994 through June 1995,4,165 new cases had been started onDOT. Ofthese,
89% were cured or completed treatment, 5% defaulted, 3%> died, 1% were treatment failures,
and 2% were transferred out. The success was attributed to the strong commitment of the
government, availability of TB drugs, hospitalization of patients during the intensive phase,
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and the distribution of free food to TB patients. Thus, even in a country like Cambodia which
has experienced genocide, war and the virtual dismantling of the health care system, DOT can
still have a significant impact.
Lay supervisors were shown to be equally effective DOT providers in a study done by
Wilkinson and Davies (1997) in Hlabisa, South Africa.

Since 1991 all patients with

tuberculosis in the Hlabisa health district, South Africa have been eligible for DOT. Patients
were supervised by either a health worker (HW), a community health worker (CHW) or a
volunteer lay person (VLP) comprised of storekeepers. By December 1995, 2,622 patients
had received DOT supervised by VLP (56%), HW (28%) and CHW (16%). Case holding
declined more for HW than for either CHW or VLP. Mortality was similar and stable over
time irrespective of the supervisor (4-6%).

Thus, community-based DOT that uses an

intermittent drug regime and volunteers as supervisors can achieve high treatment completion
rates for TB, even in resource-poor settings.
Burman, Dalton, Cohn, Butler, and Reves (1997) analyzed the cost-effectiveness of
directly observed therapy versus self-administered therapy for treatment of TB.

They

concluded that despite a greater initial cost, DOT is more cost-effective because it achieves a
higher cure rate after initial therapy and decreases treatment costs associated with failure of
therapy and acquired drug resistance. Floyd, Wilkinson, and Gilks (1997) also compared the
cost-effectiveness of DOT with that of conventional treatment based on study done in
Hlabisa, South Africa. The study concluded that DOT was 2.8 times cheaper overall than
conventional treatment ($780(US) vs $2095).
Chowdhary, Chowdhary, Islam, Islam, and Vaughan (1997) studied TB control by community
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health workers in Bangladesh. Bangladesh was among the first less developed nations to
adopt DOT.

In 1984, DOT was implemented with the help of the Bangladesh Rural

Advancement Committee (BRAC), a national nongovernmental agency (NGO).

This

program started as an experiment in one sub-district or thana. By 1995 thirteen sub-districts
were carrying out DOT. Community health workers screened villagers for chronic cough and
collected sputum samples for acid fast bacilli. Positive patients received DOT for 12 months
that was later modified to 8 months. The BRAC TB control program had a high rate of case
detection and treatment compliance, with a cure rate of 85% and dropout rate of only 3.1%.
A retrospective comparison study was done comparing patients treated with directly
observed therapy and self-administered therapy. The setting was an urban TB control
program in the US. The study compared treatment completion rates at 8 and 12 months after
treatment initiation. The study concluded that patients receiving DOT were much more likely
to complete treatment earlier (Davidson, 1998).
Based on findings such as these, Nepal initiated DOT in 1996. This study compared TB
patients from Bhaktapur district receiving DOT with patients receiving SAT in the same
district, and evaluated the two programs for compliance and success rates. The various
studies provide significant insight and possible direction. Use of voluntary lay supervisors
as was the case in Hlabisa, South Africa may have broader implication in a country such as
Nepal. It is also worthwhile to note that many of the DOT programs used enablers and
incentives, an impossibility for Nepal because of the financial constraints.

CHAPTER 3
Methodology
Research question
This research was an attempt to answer the following questions. What is the rate of
patients on DOT who completed therapy as compared to TB patients getting selfadministered therapy? What is the cure rate for patients with TB who receive DOT as
compared to TB patients getting self-administered therapy? The effectiveness of DOT was
compared against the conventional treatment program (self-administered therapy) which
served as the comparison group. The study also examined the attitude of providers towards
DOT in terms of its administration and effectiveness.
Hypotheses
The following hypotheses were tested:
1) There will be no difference in patient compliance rates between patients receiving DOT
versus those receiving self-administered therapy;
2) There will be no difference in treatment success rates between patients receiving DOT
versus those receiving self-administered therapy.
Research design
The project was a nonconcurrent cohort study. The study group were pulmonary TB
patients who had received DOT. The comparison group were pulmonary TB patients who
had received self-administered therapy or SAT. The information was collected from the
National TB Center (NTC) in Thimi, where all patient records are sent. Patients in both the
groups were active pulmonary TB cases with smear positive sputum from Bhaktapur district.
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The DOT patients had undergone treatment between 1997-1998. The SAT patients had
undergone treatment between 1996-1999. As most of the SAT clinics were replaced by
DOT, patients treated prior to 1997 were included in the SAT group to get at least 100
patients. The clinics administering DOT and SAT were not the same. There was no random
assignment of patients into the treatment groups. But being government run centers, the
DOT and SAT clinics were similar in terms of staffing, size, and activities except for the
nature of the intervention- DOT versus SAT. The clinics administering DOT and SAT were
under the Ministry of Health with free distribution of drugs. The drugs were provided by
donor agencies. The aim was to compare DOT and SAT interventions between TB patients
who come from the same district or neighboring districts with similar geographic, ethnic,
socioeconomic distribution.
The study was retrospective in nature. Data was collected from medical records and
included demographic variables, type of intervention, duration and outcome of the treatment.
The DOT providers were given a questionnaire in Nepali to get feedback about the program.
Appendix B contains the provider survey.
The study model can be constructed as
Xj Oi
X20,
where Xi represents the study group receiving DOT; X2 represents the comparison group
receiving SAT; Oi represents the posttest for each group.
Population and sample
The population consisted of all diagnosed pulmonary TB patients in Nepal.

The
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investigator selected a sample of TB patients from Bhaktapur district diagnosed and treated
between 1996 and 1999. One group of patients received DOT and the second group received
SAT. All patients who met the following criteria were included in the study: (1) active or
sputum positive patients from Bhaktapur district, (2) DOT patients diagnosed, registered, and
treated between 1997-1998, (3) SAT patients treated between 1996-1999, and (4) patients
over the age of 15.
Only pulmonary TB was considered for the study. The reason for omitting other forms of
TB was due to the variations in duration of treatment. Also, the intervention and drugs could
differ by TB type. Patients younger than 15 were not included in the study as treatment in the
pediatric age group may not be comparable to the adult group. The DOT patients were
diagnosed and treated between 1997-1998. The SAT patients were diagnosed and treated
between 1996-1999. They were diagnosed on the basis of sputum positive sample, chest xray and clinical signs and symptoms. The clinical diagnostic criteria were as follows: (1)
hemoptysis or spitting of blood-1 week, (2) evening rise of temperature-1 month, (3) cough1 month, (4) loss of weight- 1 month, and (5) loss of appetite- 1 month. The investigative
diagnostic criteria were (1) positive sputum AFB (Acid Fast Bacilli) test, and (2) positive
chest x-ray. The nature of treatment in both the clinics was the same and consisted of the
following: Rifampicin, Pyrazinamide, Isoniazid and Ethambutol for two months, followed by
Isoniazid and Ethambutol for four to six months. Total duration of treatment was six to eight
months.
Data collection
Data was collected from the medical record of each patient. Records of TB patients
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throughout the country are sent to National TB Center (NTC) in Thimi. Appendix C contains
an example of Data collection Sheet used for each patient. Appendix D contains an example
of patient medical record at NTC. Table 3 lists the variables that were extracted from each
patient's medical record. The variables included descriptive measures such as demographics,
duration and outcome of intervention.
Dependent and Independent Variables
The independent variables were the two interventions- DOT and S AT. The dependent
variables included the rate of compliance and success rate. Other potentially confounding
variables included age, gender, ethnic group, and religion.
Data analysis
Data was transcribed onto a computer data file and analyzed using the Statistical Package
for the Social Sciences (SPSS). Appropriate inferential statistics, (i.e., Chi Square) were used
to compare the study and treatment groups. Chi square test was used to compare the
treatment success rates between the DOT and SAT group. Chi Square was also used to test
the first hypothesis, compliance between the two groups.

Tables 4 and 5 show the

comparison between the two groups. The following comparisons were made between the
study and control groups: (1) treatment completion rate, and (2) success or cure rate.
Six patient outcomes were assessed within each group: (1) treatment completed, (2)
number cured, (3) treatment discontinued, (4) treatment failure, (5) number dead during the
course of treatment, and (6) number transferred out. Chi square analysis was done to test the
significance of any difference. The descriptive information obtained from the provider
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Table 3

Study variables

Category

Variables

Demographic

Age, sex, ethnic group, religion, address

Diagnostic Criteria

Sputum status, chest x-ray

Type of treatment

DOT, SAT; length of treatment

Outcomes

Treatment success or failure

25
Table

18

Compliance rate between DOT and SAT

Compliance

Study group DOT

Comparison group SAT

Number who complied

a

b

Number that did not comply

c

d

Total

a+c

b+d

26
Table

18

Success or cure rate between DOT and SAT

Cure Rate

Study group DOT

Comparison group SAT

Number cured

a

b

Number not cured

c

d

a+c

b+d

Total
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survey is described in written text. A discriminate analysis could not be done to control for
possible confounding variables because of the very high success rates in both groups.
Instrumentation
The instruments used in the study were the medical records of the patients and the selfadministered questionnaire to health providers.
Validity and reliability
This researcher obtained data from two sources: (1) medical records, and (2) provider
survey. Indicators for success or failure of treatment depended upon sputum test and chest xray results. Thus, validity was not a limitation as these are well established indicators. The
information on demographics was more subjective, dependent upon the health provider filling
out the forms and the patients who provided the information. The survey questionnaire
administered to the providers depended on their accuracy and truthfulness. This writer does
not intend to generalize the findings of clinics in Bhaktapur with all operating clinics in Nepal.

Confidentiality
When collecting data, each medical record that met with criteria for the study was given a
code number. The names of the patients were not used anywhere in the study. Only their
ethnicity was noted. The patients were referred to by their given codes. At the end of the
study, the code list was destroyed. The survey of providers was anonymous. They were
told not to disclose their name, and the survey was completely voluntary. Thus, all
reasonable safeguards were taken to ensure that patient names and provider information
remain anonymous (See Appendix E).

CHAPTER 4
Results
Description of Study Sample
A total of 261 patients were included in the study. The DOT group consisted of 161
patients, and the SAT group consisted of 100 patients. Patients in both groups were sputum
positive and had positive chest x-rays at the start of treatment. All the patients were above 15
years of age. The subjects were divided into the following age groups: 15-25, 26-35, 36-45,
46-55, and over 55 years (Table 6). The age distribution was similar for DOT and SAT, and
there was no significant difference between the two groups in terms of age (%2 =5.23; ns;
df=4) (Table 7). The gender and ethnic proportions were also similar between both groups
(Tables 8-11). The ethnic groups were divided into Brahmin, Chhetri, Newar, Tamang, and
Others.

Bhaktapur district is inhabited mostly by Newars, thus explaining the greater

proportion of Newars in both DOT and SAT. All the patients fell into two religious groupsHindus and Buddhists with the majority being Hindus (Tables 12-13).

There was no

significant difference between the two groups in terms of religion (%2 =0.54; ns; df=l).
In terms of referral, the patients fell in two main groups- National Tuberculosis Center or
NTC and others (Tables 14-15). The category Aothers= included Bhaktapur Hospital, Patan
Hospital, private clinics, etc. The majority, 229 out of 261 patients, had been referred from
NTC. The proportion in each group was similar (%2 =1.6; ns; df=l). Patient outcome was
divided into the following categories: cured, not cured, treatment discontinued, transferred,
and death (Table 16). The last four categories were lumped together into one category of not
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cured because of small cell sizes (Table 17).
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Table
Religion

12
distribution of patients

Clinic
SAT

Age group

DOT

Tota

15-25

Count
Expected count
% within age
% within group

36
38.5
35%
37.5%

67
64.5
65%
41.6%

103
103
100%

26-35

Count
Expected count
% within age
% within group

26
20.5
47.3%
27%

29
34.5
52.7%
18%

55
55
100%

36-45

Count
Expected count
% within age
% within group

10
14.6
25.6%
10.4%

29
24.4
74.4%
18%

39
39
100%

46-55

Count
Expected count
% within age
% within group

16
14.2
42.1%
16.7%

22
23.8
57.9%
13.7%

38
38
100%

55+

Count
Expected count
% within age
% within group

8
8.2
36.4%
8.3%

4
13.8
63.6%
8.7%

22
22
100%

Total

Count
Expected count
% within age
% within group

96
96
37.4%
99.9%

161
161
62.6%
100%

257
257
100%
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Table 7
Chi- square test for age distribution

Value

df

Pearson Chi- Square

5.229*

4

0.256

Likelihood Ratio

5.292

4

0.259

Linear - by- Linear Association

0.007

1

0.934

Number of valid cases

257

* 0 cells have expected count less than 5. The minimum expected count is 8.22.

Sig
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Table
Religion

12
distribution of patients

Clinic
Sex

SAT

DOT

Total

Female

Count
Expected count
% within sex
% within group

28
25
43.1%
28%

37
40
56.9%
23.1%

65
65
100%
25%

Male

Count
Expected count
% within sex
% within group

72
75
36.9%
72%

123
120
63.1%
76.9%

195
195
100%
75%

Total

Count
Expected count
% within sex
% within group

100
100
38.5%
100%

160
160
61.5%
100%

260
260
100%
100%
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Table 9
Chi - square test of sex distribution

Value

df

Asymp. Sig. Exact sig.
(2- sided)
(2 sided)

Pearson Chi-Square

0.780**

1

0.377

Continuity correction*

0.542

1

0.462

Likelihood ratio

0.773

1

0.379

Fisher=s Exact test

0.381

Linear by Linear Association 0.777
No. of valid cases

Exact sig.
(1 sided)

1

0.378

260

* Computed only for 2 x 2 table
** 0 cells have expected count less than 5. The minimum expected count is 25.0.

0.230
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Table 12
Religion

distribution of patients

Clinic

Count
Expected count
% within ethnic
% within group

Brahmin

Chhetri

Count

Total

DOT

SAT

Ethnic group

15
15
100%
5.8%

10
9.2
66.7%
6.2%

5
5.8
33.3%
5%
15

35

20
Expected count
% within ethnic
% within group

13.5
57.1%
20%

21.5
42.9%
9.4%

35
100%
13.5%

Newar

Count
Expected count
% within ethnic
% within group

47
54.8
33.1%
47%

95
87.2
66.9%
59.7%

142
142
100%
54.8%

Tamang

Count
Expected count
% within ethnic
% within group

23
20.8
42.6%
23%

31
33.2
57.4%
19.5%

54
54
100%
20.8%

Other*

Count
Expected count
% within ethnic
% within group

5
5
38.5%
5%

8
8
61.5%
5%

13
13
100
5%

Total

Count
Expected count
% within ethnic
% within group

100
100
38.6%
100%

159
159
61.4%
99.8%

259
259
100%
99.9%

Table 11
Chi- Square test of ethnic distribution

Value

df

Asymp. Sig. (2-sided)

Pearson Chi-Square

7.429*

4

0.115

Likelihood Ratio

7.294

4

0.121

Linear- by- linear Association

0.164

1

0.686

No of valid cases

259

* 0 cells have expected count less than 5. The minimum expected count is 5.02.
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Table 12
Religion distribution of patients

Clinic
SAT

Religion

DOT

Total

Hindu

Count
Expected count
% within religion
% within group

74
76.4
37.4%
74%

124
121.6
62.6%
78%

198
198
100%
76.4%

Buddhists

Count
Expected count
% within religion
% within group

26
23.6
42.6%
26%

35
37.4
57.4%
22%

61
61
100%
23.6%

Total

Count
Expected count
% within religion
% within group

100
100
38.6%
100%

159
159
61.4%
100%

259
259
100%
100%
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Table 18
Chi- Square test of religion distribution

Value

df

Asymp. Sig.
Exact sig. Exact sig.
(2- sided)
(2 sided)
(2 sided)

Pearson Chi-square

0.542*

1

0.462

Continuity correction**

0.343

1

0.558

Likelihood Ratio

0.538

1

0.463

Fisher=s Exact Test

0.548

Linear by linear Association

0.540

No. of valid cases

259

1

0.462

** Computed only for 2 x 2 table
* 0 cells have expected count less than 5. The minimum expected count is 23.55.

0.278
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Table 14
Distribution of referral clinic
Clinic
Referral

SAT

DOT

Total

NTC

Count
Expected count
% within referral
% within group

91
87.7
39.7%
91%

138
141.3
60.3%
85.7%

229
229
100%
87.7%

Other

Count
Expected count
% within referral
% within group

9
12.3
28.1%
9%

23
19.7
71.9%
14.3%

32
32
100%
12.3%

Total

Count
Expected count
% within referral
% within group

100
100
38.3%
100%

161
161
61.7%
100%

261
261
100%
100%
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Table 18
Chi- Square Test of distribution of referral clinic

Value

df

Asymp. Sig.
(2- sided)

Pearson Chi- square

1.602*

1

0.206

Continuity correction**

1.148

1

0.284

Likelihood Ratio

1.663

1

0.197

Exact sig.
(2 sided)

0.247

Fisher=s Exact Test
Linear- by- linear association 1.596
No. of valid cases

Exact sig.
(2 sided)

1

0.206

261

* * Computed only for a 2 x 2 table
* 0 cells have expected count less than 5. The minimum expected count is 12.26.

0.141
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Table 16
Distribution of outcome

Clinic
SAT

Outcome

DOT

Total

Cured

Count
Expected count
% within outcome

75
82
35%

139
132
65%

214
214
100%

Not cured

Count
Expected count
% within outcome

2
1.9
40%

3
3.1
60%

5
5
100%

rx discontinued

Count
Expected count
% within outcome

11
7.7
55%

9
12.3
45%

20
20
100%

Transferred

Count
Expected count
% within outcome

8
3.8
80%

2
6.2
20%

10
10
100%

Death

Count
Expected count
% within outcome

4
4.6
33.3%

8
7.4
66.7%

12
12
100%

Total

Count
Expected count
% within outcome

100
100
38.3%

161
161
61.7%

261
261
100%

Since four cells have minimum expected count of less than 5, the outcome was broadly
divided into outcome 1 which included the cured group and outcome 2 which included not
cured, dead, treatment discontinued and transferred.
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Table 17
Distribution of outcome

Clinic

Count
Expected count
% within outcome
% within group

SAT
75
82
35%
75%

DOT
139
132
65%
86.3%

Total
214
214
100%

Outcome 2

Count
Expected count
% within outcome
% within group

25
18
53.2%
25%

22
29
46.8%
13.4%

47
47
100%

Total

Count
Expected count
% within outcome
% within group

100
100
38.3%
100%

161
161
61.7%
99.7%

261
261
100%

Outcome
Outcome 1
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Out of 100 patients in the SAT category, 75 were cured; that is, they had completed the
treatment course and were sputum and chest x-ray negative. Out of 100, 25 were not cured
(1 l=discontinued treatment, 8=transferred and lost to follow up, 4= death, 2= chest and
sputum positive). Out of 161 patients in the DOT group, 139 were cured and 22 were not
cured (treatment discontinued=9, transferred=2, d e a t h s , sputum and x-ray positive=3).
There was a significant difference between the two groups in terms of outcome, (%2 = 5.37;
p< 0.05; df=l) (Table 18). The cure rate of the DOT group was 86.3%, while it was only
75.0% in the SAT group. The mean treatment length was 6.8 months in the SAT group and
7.4 months in the DOT group, a significant difference (F = 4.13; df=l, 256; p<0.05) (Tables
19-20). The two groups also had a significant difference in the rate of compliance (%2
-3.57; p<0.05; df=l) (Tables 21 and 22). The compliance rates were 90.2% for DOT vs
81.8% for SAT patients.
Tests of Hypotheses
Hypothesis 1- There will be no difference in compliance between patients receiving DOT
versus those receiving SAT.
A Chi-square test was performed to compare the compliance between DOT and SAT. As
can be seen from Tables 22 and 23, a significant difference was found in terms of compliance
between the two groups. Thus the null hypothesis was rejected. DOT patients were more
compliant than were SAT patients.
Hypothesis 2 - There will be no difference in treatment success rate between patients
receiving DOT versus those receiving SAT.
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Table 18

Chi-square test of patient outcome

Test

Value

Df

Asymp. Sig.
(2 sided)

Pearson Chi-square

5.368**

1

0.021

Continuity correction*

4.628

1

0.031

Likelihood ratio

5.238

1

0.022

Fisher=s Exact Test

Exact sig.

Exact sig.

(2 sided)

(1 sided)

0.03

Linear by linear association

5.348

No of valid cases

261

1

0.021

* Computed only for 2 x 2 table
** 0 cells have expected count less than 5. The minimum expected count is 18.01.

0.017

44
Table 19
Distribution of treatment length

95% confidence interval
For mean
Group No.

Mean

Std.
Dev.

Std. Error

Lower
Bound

Upper
Bound

Min

Max

SAT

98

6.831

2.4008

0.2425

6.3503

7.313

0.25

9

DOT

160

7.3846

1.9292

0.1525

7.0833

7.685

0.03

12

Total

258

7.1745

2.1332

0.1328

6.9130

7.436

0.03

12
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Table 20
Treatment leneth(ANOVA)

Group

Sum of squares

df

Mean squares

Between groups

18.581

1

18.581

Within groups

1150.881

256

4.496

Total

1169.462

257

F

Sig.

4.133

0.043

Table 21
Distribution of compliance

Clinic
SAT

DOT

Total

Count
Expected count
% within compliance
% within group

72
76.7
34.1%
81.8%

139
134.3
65.9%
90.2%

211

Non-compliant

Count
Expected count
% within compliance
% within group

16
11.3
51.6%
18.2%

15
19.7
48.4%
9.7%

31
31
100%

Total

Count
Expected count
% within compliance
% within group

88
88
36.4%
100%

154
154
63.6%
99.9%

242
242
100%

Compliant

21

100%
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Table 22
Chi-square test of compliance

Test

Value

df

Asymp. Sig.
(2 sided)

Pearson Chi-square

3.573**

1

0.059

Continuity correction*

2.857

1

0.091

Likelihood Ratio

3.45

1

0.063

Fishery Exact test
Linear by Linear Association 3.558
No of valid cases

1

Exact sig.

Exact sig.

(2 sided)

(1 sided)

0.072

0.047

0.059

242

* Computed for 2 x 2 table
** 0 cells have expected value less than 5. The minimum expected value is 11.27.
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A Chi-square test was performed to compare the outcome between the two groups. As can be
seen from Tables 18 and 19, there was a significant difference between the two groups in
terms of outcome. Thus the null hypothesis was rejected. DOT patients had a higher
treatment success rate than did SAT patients.
Summary of Provider Survey
Nine DOT providers were given questionnaire (Appendix B). The providers were as follows:
Nursing Director (Matron)-1
District TB Assistant-1
Health Post In-charge (Health Assistant)-1
Health Assistant-1
Auxiliary Nurse Midwife (ANM)-2
Lab Assistant-1
Lab Technician-1
Auxiliary Health worker-1.
The average period of working as a DOT provider was 1 year. The average length of
training received had been 1 week, with only one respondent saying that no training had been
given. The training covered sputum follow-up, patient supervision, monitoring and reporting.
One respondent said that training on health education, case detection and dispensing
medication had been given. The lab assistants said that their training consisted of conducting
Acid Fast Bacilli Stain, sputum smear, and giving medication. None of the providers said that
any type of incentives were given for patients or for themselves. All the providers said that
the medicine provided to the patients was free of cost. The providers thought that the

49
medicine was provided by the National TB Center (NTC). One provider thought that District
Health Office, Bhaktapur supplied the drugs. All the respondents felt that DOT had improved
the cure rate and patient compliance. All respondents said that they motivated patients by
giving them health education. All thought that DOT should be widely implemented in Nepal
for TB control to be effective. The reasons given were reliability, regular supply of medicine,
short course of treatment, better follow-up, and good record keeping of patients. One
respondent said that DOT could give rise to staffing problems.

Chapter 5
Conclusion
Summary of Results
Chi-square tests were used to compare patient compliance and treatment outcomes
between the DOT and SAT groups. There was significant difference in patient compliance
and outcome of treatment. Treatment length also differed between the two groups. The
difference between the two groups in terms of outcome was significant, (%2 = 5.37; p< 0.05;
dfM) (Table 19). The cure rate of the DOT group was 86.3%, while it was only 75% in the
SAT group. The mean treatment length was 6.8 months in the SAT group and 7.3 months in
the DOT group (F = 4.13; df=l, 256; p<0.05) (Tables 20 and 21). The two groups also had a
significant difference in the rate of compliance (%2 =3.57; p<0.05; df=l) (Tables 22 and 23).
Slightly over ninety percent of DOT patients were compliant, while 81.8% of SAT patients
were compliant.
Discussion

Tuberculosis is the leading cause of death in Nepal. The threat of multi-drug resistant TB
has added a sense of urgency to early detection and completing treatment regimens. The
result of this study have shown that DOT was more effective compared to the SAT method.
Even curing a single case will prevent spreading TB to many cases. Given that 45% of the
total population is infected and 10% of these develop TB, the increase in the cure rate from
75%i (SAT) to 86.3% (DOT) would prevent thousands of cases, if applicable to the whole
nation.
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A few interesting things about the patient characteristics in Nepal have been highlighted by
this study. For example, there were more male than female patients in both the groups. This
maybe representative of national health care utilization trends due to the lack of female
empowerment in a less developed country like Nepal. Females are more hesitant to visit a
medical clinic on their own. It may take up a whole day to visit the clinic. As they have to
take care of their house and family, even one day is a lot to give up. Thus, while the rate of
reported cases is higher for males, it may not be accurate because of under-utilization of
health services by females. This gender behavior appears to be the opposite of utilization
behavior in more developed countries. For example, in the United States of America, females
report higher levels of health care utilization on several measures. Thus, this serious question
is raised: how many cases go undetected and further spread the disease in countries such as
Nepal. Another important observation was that all the mortality was in the over 55 age
group. One plausible explanation is that these patients had TB for a long time and treatment
came too late. The possibility that they could have been sputum positive cases for a long time
is indeed very grave.
There were no differences between the study and control groups in terms of age
distribution, sex, religion, ethnicity, etc. Thus the two groups were comparable and did not
appear to present any confounding variables.
At the start of this study, DOT had already been widely implemented in Nepal. In fact, in
the district that I had chosen, Bhaktapur, it was more difficult to find SAT cases. So this
finding is a step in a positive direction. But there are other challenges; for example, are all
open cases being detected?

Can Nepal find the resources to continue with DOT
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implementation, as it is a labor intensive process? Will the patients always have free drugs
available to them?
Limitations
The generalizability of the results are limited because only patients in one district were
included in the study and this sample does not represent the entire population ofNepal. There
may also have been subjective variations on the part of clinic employees when filling out the
medical records.
Conclusion
Based on the study, significant differences exist between the DOT and SAT group. Two
conclusions can be drawn:
(1) Patient compliance is better in DOT versus those receiving self-administered therapy;
(2)DOT patients have a better treatment outcome than patients receiving self-administered
therapy.
The provider survey showed a very positive attitude among the providers towards
DOT, which is very important for the continuation and success of DOT programs.
However, the provider survey result should be viewed with some caution given the low
number of providers surveyed and also given that only DOT providers were surveyed.
Implication
This study showed results similar to those conducted worldwide, which has shown
DOT to be more effective in treating TB patients. This study was the first one that
compared DOT with SAT in Nepal. The results should be encouraging to Nepalese
government, health policy planners, donor agencies, DOT providers, and the TB patients
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in Nepal. The results are a positive reinforcement to the donor organizations to continue
medical and technical support to Nepal's fight against TB. Although this study showed
DOT to be better than SAT, it also revealed that in Bhaktapur even the 75% cure rate of
SAT was better than the national average of 40%. This outcome could be attributed to
the close proximity of Bhaktapur with the capital Kathmandu and the National TB Center
in Thimi. Other possible reasons include the better socioeconomic situation of inhabitants
of Bhaktapur as a large proportion are business people and farmers.
Recommendations
Since DOT will soon be implemented in all treatment facilities in Nepal, long term
plans to make it more effective, stable and lasting are needed. Such measures will mean
better cooperation among the donors, health policy planners, providers and patients. The
role of the providers should be given more importance through better trainings, feedbacks,
and encouragement. Since DOT is labor intensive it may be worthwhile to consider
training local community volunteers to administer medication and keep records. Given the
difficult terrain of Nepal where patients have to walk all day to reach the nearest heath
center, this approach may prove to be a very cost-effective and rewarding strategy.
Moreover, similar examples in rural South Africa, where conditions are little different
from those in Nepal, have shown very good results (Wilkinson et al, 1997). The
possibility of intermittent therapy should also be reviewed. Efforts should be extended to
make treatment less dependant on donors and medicines to be manufactured within Nepal.
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